Blood donation, body iron status and carotid intima-media thickness

Atherosclerosis

Volumn 196, Issue 2, 2008, Pages 856-862

  Engberink, Mariëlle F ^a   Geleijnse, Johanna M ^a   Durga, Jane ^a,b   Swinkels, Dorine W ^c   de Kort, Wim L A M ^d   Schouten, Evert G ^a   Verhoef, Petra ^a,b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Sanquin Blood Bank ^*  (Netherlands)

Author keywords

Atherosclerosis; Blood donation; Body iron status; Carotid intima media thickness; Non transferrin bound iron

Indexed keywords

FERRITIN; IRON; NON TRANSFERRIN BOUND IRON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; BLOOD DONOR; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTIMA; IRON BLOOD LEVEL; IRON OVERLOAD; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUNICA MEDIA;

AGED; ATHEROSCLEROSIS; BLOOD DONORS; CAROTID ARTERY, COMMON; FEMALE; FERRITINS; HUMANS; IRON; MALE; MIDDLE AGED; POSTMENOPAUSE; TRANSFERRIN; TUNICA INTIMA;

EID: 38549090079     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.01.031     Document Type: Article

References (34)

1. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1 (1981) 1293-1294
2. Morrison H.I., Semenciw R.M., Mao Y., and Wigle D.T. Serum iron and risk of fatal acute myocardial infarction. Epidemiology 5 (1994) 243-246
3. Salonen J.T., Nyyssonen K., Korpela H., Tuomilehto J., Seppanen R., and Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86 (1992) 803-811
4. Tuomainen T.P., Punnonen K., Nyyssonen K., and Salonen J.T. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97 (1998) 1461-1466
5. Meyers D.G., Jensen K.C., and Menitove J.E. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 42 (2002) 1135-1139
6. Meyers D.G., Strickland D., Maloley P.A., Seburg J.K., Wilson J.E., and McManus B.F. Possible association of a reduction in cardiovascular events with blood donation. Heart 78 (1997) 188-193
7. Salonen J.T., Tuomainen T.P., Salonen R., Lakka T.A., and Nyyssonen K. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Epidemiol 148 (1998) 445-451
8. Tuomainen T.P., Salonen R., Nyyssonen K., and Salonen J.T. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 314 (1997) 793-794
9. Baer D.M., Tekawa I.S., and Hurley L.B. Iron stores are not associated with acute myocardial infarction. Circulation 89 (1994) 2915-2918
10. Danesh J., and Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 99 (1999) 852-854
11. Liao Y., Cooper R.S., and McGee D.L. Iron status and coronary heart disease: negative findings from the NHANES I epidemiologic follow-up study. Am J Epidemiol 139 (1994) 704-712
12. Sempos C.T., Looker A.C., Gillum R.E., McGee D.L., Vuong C.V., and Johnson C.L. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 10 (2000) 441-448
13. Sempos C.T., Looker A.C., Gillum R.F., and Makuc D.M. Body iron stores and the risk of coronary heart disease. N Engl J Med 330 (1994) 1119-1124
14. Zheng H., Cable R., Spencer B., Votto N., and Katz S.D. Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol 25 (2005) 1577-1583
15. Kiechl S., Willeit J., Egger G., Poewe W., and Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96 (1997) 3300-3307
16. Moore M., Folsom A.R., Barnes R.W., and Eckfeldt J.H. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 141 (1995) 719-723
17. Rauramaa R., Vaisanen S., Mercuri M., Rankinen T., Penttila I., and Bond M.G. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men. Eur Heart J 15 (1994) 1020-1027
18. Cook J.D., Lipschitz D.A., Miles L.E., and Finch C.A. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 27 (1974) 681-687
19. Finch C.A., Cook J.D., Labbe R.F., and Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 50 (1977) 441-447
20. Lee D.H., and Jacobs Jr. D.R. Serum markers of stored body iron are not appropriate markers of health effects of iron: a focus on serum ferritin. Med Hypotheses 62 (2004) 442-445
21. de Valk B., Addicks M.A., Gosriwatana I., Lu S., Hider R.C., and Marx J.J. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 30 (2000) 248-251
22. Gosriwatana I., Loreal O., Lu S., Brissot P., Porter J., and Hider R.C. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 273 (1999) 212-220
23. de Valk B., and Marx J.J. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 159 (1999) 1542-1548
24. van der A.D., Marx J.J., Grobbee D.E., et al. Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women. Circulation 113 (2006) 1942-1949
25. Durga J., Bots M.L., Schouten E.G., Kok F.J., and Verhoef P. Low concentrations of folate, not hyperhomocysteinemia, are associated with carotid intima-media thickness. Atherosclerosis 179 (2005) 285-292
26. Breuer W., and Cabantchik Z.I. A fluorescence-based one-step assay for serum non-transferrin-bound iron. Anal Biochem 299 (2001) 194-202
27. Ponka P., Beaumont C., and Richardson D.R. Function and regulation of transferrin and ferritin. Semin Hematol 35 (1998) 35-54
28. Loreal O., Gosriwatana I., Guyader D., Porter J., Brissot P., and Hider R.C. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol 32 (2000) 727-733
29. Esposito B.P., Breuer W., Sirankapracha P., Pootrakul P., Hershko C., and Cabantchik Z.I. Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102 (2003) 2670-2677
30. Gutteridge J.M., Rowley D.A., Griffiths E., and Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci (Lond) 68 (1985) 463-467
31. von Bonsdorff L., Lindeberg E., Sahlstedt L., Lehto J., and Parkkinen J. Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies. Clin Chem 48 (2002) 307-314
32. Jacobs E.M., Hendriks J.C., van Tits B.L., et al. Results of an international round robin for the quantification of serum non-transferrin-bound iron: need for defining standardization and a clinically relevant isoform. Anal Biochem 341 (2005) 241-250
33. Parkes J.G., Hussain R.A., Olivieri N.F., and Templeton D.M. Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells. J Lab Clin Med 122 (1993) 36-47
34. Day S.M., Duquaine D., Mundada L.V., et al. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 107 (2003) 2601-2606